High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome

Lupus

Volumn 19, Issue 6, 2010, Pages 711-716

  Ames, P R J ^a   Matsuura, E ^b   Batuca, J R ^c   Ciampa, A ^d   Lopez, L L ^e   Ferrara, F ^f   Iannaccone, L ^f   Delgado Alves, J ^c  

^a AIREDALE GENERAL HOSPITAL   (United Kingdom)

^b OKAYAMA UNIVERSITY   (Japan)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d S G MOSCATI HOSPITAL   (Italy)

^e Division of Medicine   (United States)

^f CARDARELLI HOSPITAL   (Italy)

Author keywords

Antiphospholipid syndrome; High density lipoprotein

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY; TRIACYLGLYCEROL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATION; PRIORITY JOURNAL; THROMBOPHILIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIPHOSPHOLIPID SYNDROME; APOLIPOPROTEIN A-I; AUTOANTIBODIES; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; THROMBOSIS; YOUNG ADULT;

EID: 77951215754     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309357765     Document Type: Article

References (18)

1. Westerweel PE, Luyten RK, Koomans HA, Derksen RH, Verhaar MC Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum 2007 ; 56: 1384-1396. (Pubitemid 46764065)
2. Ames PRJ, Antinolfi I., Scenna G., Gaeta G., Margaglione M., Margarita A. Atherosclerosis in thrombotic primary antiphospholipid syndrome. J Thromb Haemost 2009 ; 7: 537-542. (Pubitemid 47528761)
3. Matsuura E., Hughes GR, Khamashta MA Oxidation of LDL and its clinical implication. Autoimmun Rev 2008 ; 7: 558-566.
4. Navab M., Reddy S., Van Lenten BJ, Anantharamaiah GM, Fogelman AM Role of dysfunctional HDL in atherosclerosis. J Lipid Res 2009 ; 50 (Suppl): S145 - S149.
5. Delgado Alves J., Ames PR, Donohue S., et al. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002 ; 46: 2686-2694. (Pubitemid 36118933)
6. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
7. Deguchi H., Pecheniuk NM, Elias DJ, Averell PM, Griffin JH High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 2005 ; 112: 893-899. (Pubitemid 41170077)
8. Eichinger S., Pecheniuk NM, Hron G., et al. High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation 2007 ; 115: 1609-1614. (Pubitemid 46648646)
9. de Souza AW, Silva NP, de Carvalho JF, D'Almeida V., Noguti MA, Sato EI Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome. Lupus 2007 ; 10: 782-787. (Pubitemid 350069790)
10. Der H., Kerekes G., Veres K., et al. Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 2007 ; 16: 497-503. (Pubitemid 47242523)
11. Jiménez S., García-Criado MA, Tàssies D., et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 2005 ; 44: 756-761. (Pubitemid 41487204)
12. Bećarević M., Andrejević S., Miljić P., Bonaci-Nikolić B., Majkić-Singh N. Serum lipids and anti-oxidized LDL antibodies in primary antiphospholipid syndrome. Clin Exp Rheumatol 2007 ; 25: 361-366. (Pubitemid 47091011)
13. Bilora F., Boccioletti V., Girolami B., et al. Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost 2002 ; 8: 103-113. (Pubitemid 34779129)
14. Kobayashi K., Kishi M., Atsumi T., et al. Circulating oxidized LDL forms complexes with 2-glycoprotein I: implication as an atherogenic autoantigen. J Lipid Res 2003 ; 44: 716-717. (Pubitemid 37279673)
15. Ames PR, Antinolfi I., Ciampa A., et al. Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease? Rheumatology 2008 ; 47: 1832-1837.
16. Medina G., Casaos D., Jara LJ, et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003 ; 62: 607-610. (Pubitemid 36760555)
17. de Carvalho JF, Borba EF, Viana VS, Bueno C., Leon EP, Bonfá E. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 2004 ; 50: 3610-3615. (Pubitemid 39488687)
18. Kontush A., Chapman JM Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006 ; 58: 342-374. (Pubitemid 44394906)